Related Experiment Videos
Non-tuberculous mycobacterial lymphadenopathy
Archives of Disease in Childhood
|February 1, 1995
Summary
Surgical node excision cured non-tuberculous mycobacterial lymphadenopathy in children. Standard treatments were ineffective, but a novel macrolide/quinolone combination showed promise in select cases.
Area of Science:
- Pediatric infectious diseases
- Surgical pathology
Background:
- Non-tuberculous mycobacterial lymphadenopathy is a challenging pediatric infection.
- Current treatment strategies often involve surgery and antimicrobials with variable success.
Purpose of the Study:
- To review the outcomes of surgical and antimicrobial treatments for non-tuberculous mycobacterial lymphadenopathy in children.
- To evaluate the efficacy of novel antimicrobial combinations.
Main Methods:
- Retrospective review of 17 pediatric cases with non-tuberculous mycobacterial lymphadenopathy.
- Analysis of surgical interventions (excision, incision) and antimicrobial regimens.
Main Results:
- Complete node excision was curative in all cases.
- Incision of affected nodes resulted in persistent discharging lesions.
- Standard antituberculous therapies were largely ineffective.
- A macrolide/quinolone combination demonstrated effectiveness in three treated children.
Conclusions:
- Surgical excision is the definitive treatment for pediatric non-tuberculous mycobacterial lymphadenopathy.
- Incision alone is insufficient and can lead to complications.
- Novel macrolide/quinolone regimens represent a promising therapeutic option for refractory cases.